Identifying breast cancer patients most
✍
Christopher M. Booth; Joseph L. Pater; Paul E. Goss
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 38 KB
Identifying Breast Cancer Patients Most Likely to Benefit From Aromatase Inhibitor Therapy After Adjuvant Tamoxifen W e are responding to the recently published study by Freedman and colleagues in which it is suggested that the benefits of adding an aromatase inhibitor after 5 years of adjuvant tamo